Deutsche Bank initiated coverage of Xenon Pharmaceuticals (XENE) with a Buy rating and $67 price target Maximize Your Portfolio with Data ...
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 14.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 283,899 shares of ...
Understanding the behavior of tiny droplets in our cells could aid the search for new treatments. A team of Leiden ...
Combining concepts from statistical physics with machine learning, researchers at the University of Bayreuth have shown that ...
After hours: February 11 at 4:25:59 PM EST Loading Chart for XENE ...
VANCOUVER, British Columbia and BOSTON, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering ...
Forcing a struggling child to take any medicine can lead to vomiting or choking. Using a better technique can sometimes get rid of the child's resistance. Doctors can sometimes replace a bad-tasting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback